{"id":"https://openalex.org/W2018734256","doi":"https://doi.org/10.1111/j.1365-2133.1995.tb08632.x","title":"Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics","display_name":"Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W2018734256","doi":"https://doi.org/10.1111/j.1365-2133.1995.tb08632.x","mag":"2018734256","pmid":"https://pubmed.ncbi.nlm.nih.gov/7756158"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2133.1995.tb08632.x","doi":"https://doi.org/10.1111/j.1365-2133.1995.tb08632.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.1995.tb08632.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073606220","display_name":"F Nejjam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"F. NEJJAM","raw_affiliation_strings":["H\u00f4pital Ibnou Rochd, Casablanca, Morocco","H\u00f4pital Ibnou Rochd, Casabianca. Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Ibnou Rochd, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534"]},{"raw_affiliation_string":"H\u00f4pital Ibnou Rochd, Casabianca. Morocco","institution_ids":["https://openalex.org/I4210138534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028493801","display_name":"M. ZAGULA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. ZAGULA","raw_affiliation_strings":["Laboratoires Sundoz, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoires Sundoz, Rueil-Malmaison, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057376098","display_name":"M. D. Cabiac","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.D. CABIAC","raw_affiliation_strings":["Laboratoires Sundoz, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoires Sundoz, Rueil-Malmaison, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063656167","display_name":"N. Guessous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"N. GUESSOUS","raw_affiliation_strings":["Ho\u0302pital Ibnou Rochd, Casabianca. Morocco","H\u00f4pital Ibnou Rochd, Casabianca. Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ho\u0302pital Ibnou Rochd, Casabianca. Morocco","institution_ids":["https://openalex.org/I4210138534"]},{"raw_affiliation_string":"H\u00f4pital Ibnou Rochd, Casabianca. Morocco","institution_ids":["https://openalex.org/I4210138534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040646850","display_name":"Henri Humbert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"H. HUMBERT","raw_affiliation_strings":["Laboratoires Sundoz, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoires Sundoz, Rueil-Malmaison, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111843219","display_name":"H. Lakhdar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"H. LAKHDAR","raw_affiliation_strings":["Ho\u0302pital Ibnou Rochd, Casabianca. Morocco","H\u00f4pital Ibnou Rochd, Casabianca. Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ho\u0302pital Ibnou Rochd, Casabianca. Morocco","institution_ids":["https://openalex.org/I4210138534"]},{"raw_affiliation_string":"H\u00f4pital Ibnou Rochd, Casabianca. Morocco","institution_ids":["https://openalex.org/I4210138534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040646850"],"corresponding_institution_ids":[],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":9.7225,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.98379182,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"132","issue":"1","first_page":"98","last_page":"105"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/terbinafine","display_name":"terbinafine","score":1.0},{"id":"https://openalex.org/keywords/tinea-capitis","display_name":"tinea capitis","score":1.0},{"id":"https://openalex.org/keywords/pediatric-dermatophytosis","display_name":"pediatric dermatophytosis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/oral-antifungal-therapy","display_name":"oral antifungal therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.878000020980835},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.7990000247955322},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7789999842643738},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5630000233650208},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cultural-conversion","display_name":"culture conversion","score":0.7269999980926514},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2778236110","wikidata":"https://www.wikidata.org/wiki/Q415259","display_name":"Terbinafine","level":4,"score":0.9708357453346252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8271254897117615},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8194922208786011},{"id":"https://openalex.org/C2778217265","wikidata":"https://www.wikidata.org/wiki/Q650766","display_name":"Tinea capitis","level":2,"score":0.758884072303772},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.514863133430481},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4219602346420288},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.41710591316223145},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.40166717767715454},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36542242765426636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3445274233818054},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.09336420893669128},{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.05941575765609741}],"mesh":[{"descriptor_ui":"D000077291","descriptor_name":"Terbinafine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014006","descriptor_name":"Tinea Capitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2133.1995.tb08632.x","doi":"https://doi.org/10.1111/j.1365-2133.1995.tb08632.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.1995.tb08632.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:7756158","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7756158","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W43826506","https://openalex.org/W1978060756","https://openalex.org/W1989789102","https://openalex.org/W2016740000","https://openalex.org/W2041055522","https://openalex.org/W2048648126","https://openalex.org/W2054580848","https://openalex.org/W2059880669","https://openalex.org/W2063342912","https://openalex.org/W2084271174","https://openalex.org/W4255502991"],"related_works":["https://openalex.org/W2122262049","https://openalex.org/W1976906595","https://openalex.org/W2060780897","https://openalex.org/W2024639560","https://openalex.org/W2357034212","https://openalex.org/W2001421681","https://openalex.org/W2742089763","https://openalex.org/W2028393629","https://openalex.org/W2139441630","https://openalex.org/W2099163512"],"abstract_inverted_index":{"In":[0],"an":[1],"open":[2],"pilot":[3],"study,":[4],"12":[5],"children":[6,115,159],"with":[7,15,117,119],"tinea":[8],"capitis":[9],"were":[10,41],"treated":[11],"for":[12],"6":[13,133],"weeks":[14,24,67],"oral":[16],"terbinafine":[17,113],"(125":[18,166],"mg/day),":[19],"and":[20,35,51,99,122,144,160],"followed":[21],"up":[22],"2":[23],"later.":[25],"The":[26,70,105,153],"study":[27],"was":[28,53],"conducted":[29],"to":[30,72,78,83,86,90,148],"evaluate":[31],"the":[32,45,48,151],"efficacy,":[33],"safety":[34],"pharmacokinetics":[36],"of":[37,47,56,68,112],"terbinafine.":[38],"All":[39],"patients":[40],"completely":[42],"cured":[43],"at":[44,58,93,162],"end":[46],"treatment":[49],"period,":[50],"there":[52],"no":[54],"evidence":[55],"relapse":[57],"follow-up.":[59],"Seven":[60],"had":[61],"a":[62,102,109,127,163],"negative":[63,79],"culture":[64,74],"after":[65,140],"3":[66],"treatment.":[69],"time":[71],"obtain":[73],"conversion":[75],"from":[76,150],"positive":[77],"did":[80],"not":[81],"appear":[82],"be":[84],"related":[85,147],"body":[87],"weight,":[88],"but":[89],"clinical":[91],"severity":[92],"baseline.":[94],"Terbinafine":[95],"is":[96,135,146],"well":[97],"tolerated":[98],"safe":[100],"over":[101],"56-day":[103],"period.":[104],"kinetic":[106],"data":[107],"show":[108],"higher":[110],"clearance":[111],"in":[114,138],"compared":[116],"adults,":[118,139],"shorter":[120],"alpha-":[121],"beta-phase":[123],"elimination":[124,149],"half-lives.":[125],"However,":[126],"longer":[128],"terminal":[129],"gamma-phase":[130],"(at":[131],"least":[132],"days)":[134],"observed,":[136],"as":[137],"multiple":[141],"dose":[142],"administration,":[143],"this":[145],"tissues.":[152],"plasma":[154],"concentrations":[155],"are":[156],"comparable":[157],"between":[158],"adults":[161],"steady":[164],"state":[165],"mg/day).":[167]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}